Assessment of DBS technology for the detection of therapeutic antibodies

Bioanalysis

Volumn 2, Issue 8, 2010, Pages 1449-1460

  Prince, Peter J ^a   Matsuda, Katherine C ^a   Retter, M W ^a   Scott, G ^a  

^a AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY;

ACCURACY; ANTIBODY DETECTION; ARTICLE; BLOOD SAMPLING; CHEMOLUMINESCENCE; CONTROLLED STUDY; DRIED BLOOD SPOT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEASIBILITY STUDY; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; NONHUMAN; QUANTITATIVE ANALYSIS; RAT; REPRODUCIBILITY; SENSITIVITY ANALYSIS; VALIDATION STUDY; ANIMAL; BLOOD; BLOOD ANALYSIS; DESICCATION; IMMUNOLOGY; METHODOLOGY; SPRAGUE DAWLEY RAT; STATISTICAL MODEL;

ANIMALS; ANTIBODIES; BLOOD CHEMICAL ANALYSIS; BLOOD SPECIMEN COLLECTION; DESICCATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEASIBILITY STUDIES; HUMANS; LINEAR MODELS; RATS; RATS, SPRAGUE-DAWLEY; REPRODUCIBILITY OF RESULTS;

EID: 79953135696     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.10.97     Document Type: Article

References (13)

1. Guthrie R, Susi A. A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants. Pediatrics 32, 338-343 (1963).
2. Edelbroek PM, van der Heijden J, Stolk LM. Dried blood spot methods in therapeutic drug monitoring: methods, assay, and pitfalls. Ther. Drug Monit. 31, 327-336 (2009).
3. Langkamp M, Weber K, Ranke MB. Human growth hormone measurement by means of a sensitive ELISA of whole blood spots on flter paper. Growth Horm. IGF Res. 18, 526-532 (2008).
4. Tan MAF, Dean CJ, Hopwood JJ, Meikle PJ. Diagnosis of metachromatic leukodystrophy by immune quantifcation of arylsulphatase, a protein and activity in dried blood spots. Clin. Chem. 54(11), 1925-1927 (2008).
5. Wang XL, Wilcken DE, Dudman NP. An indirect sandwich ELISA for LP(a) in serum and dried blood spots. Clin. Chim. Acta 207, 73-86 (1992).
6. Corran PH, Cook J, Lynch C et al. Dried blood spots as a source of anti-malarial antibodies for epidemiological studies. Malar. J. 7, 195-207 (2008).
7. DeSilva B, Smith W, Weiner R et al. Recommendations for the bioanalytical method validation of ligand-binding assays to support pharmacokinetic assessments of macromolecules. Pharm. Res. 20(11), 1885-1900 (2003). (Pubitemid 37449466)
8. US Food and Drug Administration. Guidance for Industry: Bioanalytical Method Validation. US Department of Health and Human Services, FDA, Drug Information Branch (HFD-210), Center for Drug Evaluation and Research (CDER), 5600 Fishers Lane, Rockville, MD, USA (May 2001).
9. Booth BP. Welcome to Bioanalysis. Bioanalysis 1(1), 1-2 (2009).
10. Hill H. Development of Bioanalysis: a short history. Bioanalysis 1(1), 3-7 (2009).
11. Spooner N, Lad R, Barfeld M. Dried blood spots as a sample collection technique for the determination of pharmacokinetics in clinical studies: considerations for the validation of qualitative bioanalytical method. Anal. Chem. 81, 1557-1563 (2009).
12. McDade TW. Measuring immune function: markers of cell-mediated immunity and infammation in dried blood spots. In: Measuring Stress in Humans: A Practical Guide for the Field. Ice GH, James GD (Ed.). Cambridge University Press Publishers, 181-209 (2007).
13. Ferraz AS, Belo EF, Coutinho LM et al. Storage and stability of IgG and IgM monoclonal antibodies dried on flter paper and utility in Neisseria meningitidis serotyping by Dot-blot ELISA. BMC Infect. Dis. 8, 30-38 (2008).